Search results for "2270*"

showing 10 items of 1052 documents

Impaired cognitive control over emotional material in euthymic bipolar disorder.

2016

Abstract Background Previous research suggests that bipolar disorder (BD) is characterized by deficits in cognitive control (CC). Impaired CC has been found in high-risk samples and is associated with the maintenance of BD symptoms. It remains unclear, however, whether BD is characterized by a general deficit in CC or by a deficit that is specifically related to the processing of emotional material. Methods The sample consisted of 42 remitted bipolar patients and 39 healthy controls (HC). We examined whether BD individuals display impaired CC when confronted with negative as well as positive material using an arithmetic inhibition task that required inhibition of pictorial stimulus material…

AdultMalemedicine.medical_specialtyBipolar DisorderEmotionsCognitionAudiologyStimulus (physiology)medicine.disease030227 psychiatry03 medical and health sciencesPsychiatry and Mental healthClinical Psychology0302 clinical medicinemedicineHumansFemaleBipolar disorderPsychologyPsychiatryCognition Disorders030217 neurology & neurosurgeryJournal of affective disorders
researchProduct

Peripheral Oxidative Stress Markers in Patients with Bipolar Disorder during Euthymia and in Siblings.

2020

Aims:Oxidative stress is increased during the acute phases of bipolar disorder (BD). Our aim here was to analyze oxidative stress biomarkers in patients with BD during euthymia and their siblings.Method:A cross-sectional study was performed in euthymic patients with BD-I (n=48), unaffected siblings (n=23) and genetically unrelated healthy controls (n=21). Protein carbonyl content (PCC), total antioxidant capacity (TRAP), lipid peroxidation (TBARS) and uric acid were measured as biomarkers of oxidative stress in blood.Results:The antioxidant capacity (TRAP) was lower (p<0.001) in patients with BD compared to their siblings and controls, whereas no differences were observed in PCC, TBARS o…

AdultMalemedicine.medical_specialtyBipolar DisorderEndocrinology Diabetes and MetabolismProtein Carbonyl Contentmedicine.disease_causeThiobarbituric Acid Reactive SubstancesLipid peroxidationProtein Carbonylation03 medical and health scienceschemistry.chemical_compound0302 clinical medicineAntimanic AgentsInternal medicineTBARSImmunology and AllergyMedicineHumansBipolar disorderValproic Acidbusiness.industrySiblingsValproic AcidMiddle Agedmedicine.disease030227 psychiatryUric AcidOxidative StressEndocrinologyCross-Sectional StudieschemistryCase-Control StudiesBiomarker (medicine)Uric acidFemaleLipid Peroxidationbusiness030217 neurology & neurosurgeryOxidative stressBiomarkersmedicine.drugEndocrine, metabolicimmune disorders drug targets
researchProduct

Disruption of White Matter Integrity in Bipolar Depression as a Possible Structural Marker of Illness

2011

Background: Diffusion tensor imaging allows the study of integrity of white matter (WM) tracts. Literature suggests that WM integrity could be altered in bipolar disorder. Heterogeneity of brain imaging methods, the studied samples, and drug treatments make localization, nature, and severity of the WM abnormalities unclear. Methods: We applied tract-based spatial statistics of diffusion tensor imaging measures to compare fractional anisotropy (FA), mean, and radial diffusivity of the WM skeleton in a group of 40 consecutively admitted inpatients affected by a major depressive episode without psychotic features with a diagnosis of bipolar disorder type I and 21 unrelated healthy volunteers f…

AdultMalemedicine.medical_specialtyBipolar DisorderGenu of the corpus callosumImage ProcessingPopulationSpleniumCorpus callosumNerve Fibers MyelinatedWhite matter03 medical and health sciencesComputer-AssistedNerve Fibers0302 clinical medicineInternal medicineFractional anisotropyImage Processing Computer-AssistedmedicineHumanseducationBiological PsychiatryBrain Mappingeducation.field_of_studyAdult; Anisotropy; Bipolar Disorder; pathology; Brain Mapping; Brain; Diffusion Tensor Imaging; Female; Humans; Image Processing; Computer-Assisted; Male; Middle Aged; Nerve Fibers; MyelinatedSuperior longitudinal fasciculusBrainMiddle Aged030227 psychiatry3. Good healthDiffusion Tensor Imagingmedicine.anatomical_structureCardiologyMyelinatedAnisotropypathologyFemalePsychologyNeuroscience030217 neurology & neurosurgeryDiffusion MRIBiological Psychiatry
researchProduct

Reward anticipation revisited- evidence from an fMRI study in euthymic bipolar I patients and healthy first-degree relatives.

2017

Abstract Background Symptomatic phases in bipolar disorder (BD) are hypothesized to result from a hypersensitive behavioral activation system (BAS) being sensitive to potential rewards. However, studies on the neuronal underpinnings of reward anticipation in BD are scarce with contradictory findings and possibly confounded by effects of dopaminergic medication, necessitating further research on dysfunctional motivation in BD. Moreover, its role as vulnerability marker for BD is unclear. Methods Functional imaging was conducted in 16 euthymic BD-I patients free from dopaminergic medication and 19 healthy first-degree relatives using a monetary incentive delay task and compared to parallelize…

AdultMalemedicine.medical_specialtyBipolar DisorderGyrus Cinguli03 medical and health sciences0302 clinical medicineRewardmedicineHumansFamilyBipolar disorderFirst-degree relativesPsychiatryAnterior cingulate cortexMotivationVentral striatumDopaminergicBehavioral activationmedicine.diseaseAnticipationMagnetic Resonance Imaging030227 psychiatryFunctional imagingPsychiatry and Mental healthClinical Psychologymedicine.anatomical_structureFemalePsychologypsychological phenomena and processes030217 neurology & neurosurgeryClinical psychologyJournal of affective disorders
researchProduct

Lithium prevents grey matter atrophy in patients with bipolar disorder: an international multicenter study

2020

AbstractBackgroundLithium (Li) is the gold standard treatment for bipolar disorder (BD). However, its mechanisms of action remain unknown but include neurotrophic effects. We here investigated the influence of Li on cortical and local grey matter (GM) volumes in a large international sample of patients with BD and healthy controls (HC).MethodsWe analyzed high-resolution T1-weighted structural magnetic resonance imaging scans of 271 patients with BD type I (120 undergoing Li) and 316 HC. Cortical and local GM volumes were compared using voxel-wise approaches with voxel-based morphometry and SIENAX using FSL. We used multiple linear regression models to test the influence of Li on cortical an…

AdultMalemedicine.medical_specialtyBipolar DisorderLithium (medication)[SDV]Life Sciences [q-bio]UrologyGrey matterGyrus CinguliHippocampus03 medical and health sciences0302 clinical medicineAtrophyAntimanic AgentsmedicineHumansIn patientBipolar disorderGray MatterPathologicalApplied PsychologyComputingMilieux_MISCELLANEOUSGrey matter atrophybusiness.industryConfoundinggrey matter volumeMiddle Agedmedicine.diseaseMagnetic Resonance ImagingTemporal Lobe3. Good health030227 psychiatryPsychiatry and Mental healthmedicine.anatomical_structurelithiumCase-Control StudiesLithium CompoundsFemaleAtrophybusiness030217 neurology & neurosurgeryMRImedicine.drug
researchProduct

Duration of euthymia and predominant polarity in bipolar disorder.

2018

The concept of Predominant Polarity (PP) provides relevant information for clinical practice and has been widely described as course specifier for Bipolar Disorder (BD), however it has not been incorporated in DSM-5 yet. A descriptive study was conducted to identify clinical patterns associated with PP in outpatients attending a Mental Health Unit.Clinical and socio-demographic characteristics were assessed from a sample of 118 euthymic outpatients fulfilling DSM 5 criteria for BDI or II recruited at a catchment area. According to their PP, patients were divided into three subgroups: depressive (DPP; 39.0%), manic (MPP; 32.2%) or indeterminate (IPP; 28.8%). Subgroups of PP were compared reg…

AdultMalemedicine.medical_specialtyBipolar DisorderTime FactorsCross-sectional studyPolarity (physics)DSM-503 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansBipolar disorderDepression (differential diagnoses)Demographybusiness.industryMiddle Agedmedicine.diseaseMental healthCyclothymic Disorder030227 psychiatryDiagnostic and Statistical Manual of Mental DisordersHospitalizationPsychiatry and Mental healthClinical PsychologyCross-Sectional StudiesMental HealthPsychotic DisordersSample size determinationFemalemedicine.symptombusinessMania030217 neurology & neurosurgeryJournal of affective disorders
researchProduct

Do patients with bipolar disorder and subsyndromal symptoms benefit from functional remediation? A 12-month follow-up study

2016

We analyzed the efficacy of functional remediation, in a sample of patients with bipolar disorder who presented with subsyndromal symptoms. From a total sample of 239 patients with bipolar I and II disorder, according to DSM-IV-TR diagnostic criteria, entering a randomized clinical trial, those patients who presented with subsyndromal symptoms were selected based on a method already described by Berk and colleagues was applied. It consists of using the Clinical Global Impression-Bipolar version (CGI-BP) to establish the scores of the Hamilton Depression Rating Scale (HAM-D) and of the Young Mania Rating Scale (YMRS) that correspond with 1 in the CGI-BP. Functional outcome and mood symptoms …

AdultMalemedicine.medical_specialtyBipolar Disordermedicine.medical_treatmentYoung Mania Rating Scalelaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialRating scalelawmental disordersmedicinePsychoeducationHumansPharmacology (medical)Bipolar disorderBiological PsychiatryDepression (differential diagnoses)Psychiatric Status Rating ScalesPharmacologyAnalysis of VarianceChi-Square DistributionMiddle Agedmedicine.diseaseCognitive Remediation030227 psychiatryPsychotherapyPsychiatry and Mental healthTreatment OutcomeMoodNeurologyPhysical therapyFemaleNeurology (clinical)PsychologyPsychosocial030217 neurology & neurosurgeryFollow-Up StudiesClinical psychologyEuropean Neuropsychopharmacology
researchProduct

Dysfunctional decision-making related to white matter alterations in bipolar I disorder.

2015

Abstract Objective This study investigated how frontal white matter (WM) alterations in patients with bipolar I disorder (BD-I) are linked to motivational dysregulation, often reported in the form of risk-taking and impulsivity, and whether structure–function relations in patients might differ from healthy subjects (HC). Method We acquired diffusion data from 24 euthymic BD-I patients and 24 controls, to evaluate WM integrity of selected frontal tracts. Risk-taking was assessed by the Cambridge Gambling Task and impulsivity by self-report with the Barratt-Impulsiveness Scale. Results BD-I patients displayed significantly lower integrity in the right cingulum compared to HC. They also showed…

AdultMalemedicine.medical_specialtyBipolar I disorderBipolar DisorderDecision MakingAudiologyImpulsivityWhite matter03 medical and health sciences0302 clinical medicineRisk-TakingFasciculusmedicineCingulum (brain)HumansBipolar disorderPsychiatrybiologyAlcohol dependenceCase-control studyMiddle Agedbiology.organism_classificationmedicine.diseaseWhite Matter030227 psychiatryPsychiatry and Mental healthClinical Psychologymedicine.anatomical_structureCase-Control StudiesImpulsive BehaviorFemaleSelf Reportmedicine.symptomNerve NetPsychology030217 neurology & neurosurgeryJournal of affective disorders
researchProduct

A combined marker of early non-improvement and the occurrence of melancholic features improve the treatment prediction in patients with Major Depress…

2017

Abstract Background Early Improvement of depressive symptoms within two weeks of antidepressant treatment is a highly sensitive but less specific predictor of later treatment outcome. The aim of this study was to identify clinical features at treatment initiation which are associated with early improvement and non-improvement as well as to identify variables predicting non-remission in patients showing an early improvement. Methods 889 patients with a major depressive episode according to DSM-IV who had participated in an antidepressant treatment trial served as study sample. Clinical predictors (demographic variables, psychopathology, comorbid disorders) were analysed in 698 (79%) early im…

AdultMalemedicine.medical_specialtyComorbidityAvoidant personality disorderPatient ReadmissionSeverity of Illness IndexSuicidal Ideation03 medical and health sciences0302 clinical medicineRisk FactorsRating scaleInternal medicinemedicineHumansMajor depressive episodePsychiatryAtypical depressionDepression (differential diagnoses)Depressive Disorder Majorbusiness.industryMiddle Agedmedicine.diseaseAntidepressive Agents030227 psychiatryPsychiatry and Mental healthClinical PsychologyTreatment OutcomeMajor depressive disorderAntidepressantFemalemedicine.symptombusiness030217 neurology & neurosurgeryPsychopathologyJournal of Affective Disorders
researchProduct

Body mass index (BMI) in major depressive disorder and its effects on depressive symptomatology and antidepressant response

2019

Obesity is one of the most prevalent somatic comorbidities of Major Depressive Disorder (MDD). We aimed to investigate the relationship between body mass index (BMI) and MDD, the symptomatology of the disorder as well as the outcome of antidepressant treatment.Early medication change (EMC) trial participants with BMI measurement (n = 811) were categorized according to WHO-criteria in normal or low weight (BMI  25), overweight (25- 30), and obese (≥30). Depression severity and BMI was assessed in weekly intervals up to 8 weeks. BMI at baseline and course of BMI during the study were investigated in linear regression models as possible moderators of therapy response. Possible moderators such …

AdultMalemedicine.medical_specialtyComorbidityOverweightWeight GainBody Mass IndexDepressive symptomatology03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansObesityDepression (differential diagnoses)Depressive Disorder Majorbusiness.industryMiddle Agedmedicine.diseaseObesityAntidepressive Agents030227 psychiatryPsychiatry and Mental healthClinical PsychologyAntidepressantMajor depressive disorderFemalemedicine.symptombusinessWeight gainBody mass index030217 neurology & neurosurgeryJournal of Affective Disorders
researchProduct